TruthOrFake Logo
TruthOrFake
Fact Check: long covid is rising

Fact Check: long covid is rising

Published April 9, 2025
ByFactChecker 1.1 avatarFactChecker 1.1
✗
VERDICT
False

# Long COVID is Rising: A Detailed Examination ## Introduction The claim that "long COVID is rising" suggests an increase in the prevalence of long C...

Long COVID is Rising: A Detailed Examination

Introduction

The claim that "long COVID is rising" suggests an increase in the prevalence of long COVID symptoms among individuals who have previously contracted COVID-19. This assertion raises important questions about the current state of long COVID, its impact on public health, and the reliability of the data supporting this claim.

What We Know

Long COVID, also known as post-acute sequelae of SARS-CoV-2 infection (PASC), refers to a range of symptoms that persist for weeks or months after the initial COVID-19 infection. According to various sources, the prevalence of long COVID among U.S. adults has been documented as follows:

  1. Current Prevalence: As of 2023, approximately 6.4% of noninstitutionalized U.S. adults reported experiencing long COVID at the time of the survey, with significant activity limitations reported by 12.8% to 29.4% of those affected, depending on the region 23.

  2. Historical Data: A 2022 report indicated that 6.9% of adults had ever experienced long COVID, with 3.4% currently affected at that time 1. This suggests a relatively stable prevalence over the past year.

  3. Demographic Variability: The prevalence of long COVID varies by age and gender, with adults aged 35-49 being the most affected group 1. Additionally, a study found that about 14% of respondents reported experiencing long COVID at some point, with half of those reporting symptoms at the time of the survey 9.

  4. Trends Over Time: Research indicates that after an initial decline in prevalence, rates of long COVID have stabilized since early 2023 37. This stabilization contrasts with earlier fluctuations observed in previous months.

Analysis

The claim that long COVID is rising necessitates a critical evaluation of the data sources and methodologies used to assess prevalence.

  1. Source Reliability: The Centers for Disease Control and Prevention (CDC) is a primary source for long COVID data, providing multiple reports and surveys that are generally considered reliable due to their rigorous data collection methods. However, it is essential to note that the CDC's findings can be influenced by various factors, including survey design and response rates 123.

  2. Potential Biases: While the CDC is a reputable source, other studies may have varying degrees of reliability. For instance, studies published in peer-reviewed journals, such as those found in PubMed Central, often undergo rigorous peer review, which can enhance their credibility 69. However, the variability in reported symptoms and definitions of long COVID can lead to discrepancies in prevalence estimates, as noted in a study that cites a range of 5% to 30% for long COVID incidence 6.

  3. Methodological Concerns: The methodologies employed in these studies are crucial for interpreting the data. For example, surveys that rely on self-reported symptoms may be subject to recall bias, where individuals may not accurately remember their health status or may misinterpret their symptoms as long COVID. Additionally, the definitions of long COVID can vary, complicating comparisons across studies 510.

  4. Conflicts of Interest: Some studies may have conflicts of interest, particularly if they are funded by organizations with vested interests in the outcomes. Transparency regarding funding sources and potential biases is essential for evaluating the reliability of the findings.

What Additional Information Would Be Helpful?

To further evaluate the claim that long COVID is rising, additional longitudinal studies tracking the same cohort over time would be beneficial. This would help clarify trends in prevalence and the long-term impacts of COVID-19. Furthermore, more granular data on demographic factors, including socioeconomic status and pre-existing health conditions, could provide deeper insights into which populations are most affected.

Conclusion

Verdict: False

The claim that long COVID is rising is not supported by the available evidence. Current data indicates a stable prevalence of long COVID symptoms, with approximately 6.4% of U.S. adults reporting long COVID in 2023, which is consistent with previous estimates from 2022. While there are fluctuations in reported symptoms and demographic variability, the overall trend suggests stabilization rather than an increase.

It is important to recognize that the data on long COVID is complex and can be influenced by various factors, including survey methodologies and definitions of long COVID. Additionally, the reliance on self-reported symptoms may introduce biases that affect the accuracy of prevalence estimates.

Given these limitations, readers should approach claims about long COVID with caution and critically evaluate the information presented. Ongoing research and more comprehensive studies are necessary to fully understand the long-term impacts of COVID-19 and the dynamics of long COVID prevalence.

Sources

  1. Centers for Disease Control and Prevention. (2023). Data Briefs - Number 480 - September 2023. Retrieved from CDC
  2. Centers for Disease Control and Prevention. (2023). Notes from the Field: Long COVID and Significant Long. Retrieved from CDC
  3. Centers for Disease Control and Prevention. (2023). Long COVID and Significant Activity Limitation Among Adults. Retrieved from CDC
  4. Centers for Disease Control and Prevention. (2023). Prevalence Reporting Current Long COVID and Significant Activity Limitation. Retrieved from CDC
  5. National Center for Health Statistics. (2023). Prevalence of Long COVID Among Adults Who Have Ever Had COVID-19. Retrieved from NCBI
  6. Regunath, H. (2023). Long COVID: Where Are We in 2023? Retrieved from PMC
  7. Long COVID and Significant Activity Limitation Among Adults, by Age. (2023). Retrieved from PubMed
  8. Prevalence of Long COVID Among Adults Who Have Ever Had COVID-19. (2023). Retrieved from PubMed
  9. Blanchflower, D. G. (2023). Long COVID in the United States. Retrieved from PMC
  10. The Epidemiology of Long Coronavirus Disease in US Adults. (2023). Retrieved from PubMed

Have a claim you want to verify? It's 100% Free!

Our AI-powered fact-checker analyzes claims against thousands of reliable sources and provides evidence-based verdicts in seconds. Completely free with no registration required.

💡 Try:
"Coffee helps you live longer"
✓100% Free
✓No Registration
✓Instant Results

Comments

Leave a comment

Loading comments...

More Fact Checks to Explore

Discover similar claims and stay informed with these related fact-checks

Fact Check: Covid nimbus. Here's the symptom you need to know about that nobody's talking about. What's that? You haven't heard of COVID nimbus? Probably need to talk about that too. So let's get to it. Stick to the end. I'll talk a little bit about prevention. So COVID nimbus is the newest variant going on. It is NB. 1. 8. 1. Say that three times fast. And the unfortunate part about this is it looks like it's more contagious than other variants that we've had recently but it doesn't look so bad that it's going to wind you up necessarily in the hospital. But if you followed me at all you know that that's not necessarily the worst thing 00:32 that happens. You can still develop long COVID from any COVID infection that you get no matter how serious it is or not. But it has a gnarly symptom we have not really seen with COVID in the past. And it mimics other things that we see this tiny year so it's going to be even more important that you test for it when you start getting sick. And it's being associated with razor blades. I know it's not from when you pee so don't worry about that one. Don't go down that road. It's at being associated with the sensation of swallowing razor blades because it causes such a severe sore throat it is akin 01:06 to that sensation. And that can be a similar symptom to a lot of other things particularly things we see in kids like strep throat. Or in older kids things like mononucles. Which you also see surges in usually in summer. But prevention things seem to work the same as they've been working. So vaccinate and if you can get a booster and you haven't like in the last three to six months talk to your doctor about doing so. If you are at high risk and have autoimmune issues or autoimmune suppressants do like I did which is get monoclonal antibodies to protect you
Partially True
🎯 Similar

Fact Check: Covid nimbus. Here's the symptom you need to know about that nobody's talking about. What's that? You haven't heard of COVID nimbus? Probably need to talk about that too. So let's get to it. Stick to the end. I'll talk a little bit about prevention. So COVID nimbus is the newest variant going on. It is NB. 1. 8. 1. Say that three times fast. And the unfortunate part about this is it looks like it's more contagious than other variants that we've had recently but it doesn't look so bad that it's going to wind you up necessarily in the hospital. But if you followed me at all you know that that's not necessarily the worst thing 00:32 that happens. You can still develop long COVID from any COVID infection that you get no matter how serious it is or not. But it has a gnarly symptom we have not really seen with COVID in the past. And it mimics other things that we see this tiny year so it's going to be even more important that you test for it when you start getting sick. And it's being associated with razor blades. I know it's not from when you pee so don't worry about that one. Don't go down that road. It's at being associated with the sensation of swallowing razor blades because it causes such a severe sore throat it is akin 01:06 to that sensation. And that can be a similar symptom to a lot of other things particularly things we see in kids like strep throat. Or in older kids things like mononucles. Which you also see surges in usually in summer. But prevention things seem to work the same as they've been working. So vaccinate and if you can get a booster and you haven't like in the last three to six months talk to your doctor about doing so. If you are at high risk and have autoimmune issues or autoimmune suppressants do like I did which is get monoclonal antibodies to protect you

Detailed fact-check analysis of: Covid nimbus. Here's the symptom you need to know about that nobody's talking about. What's that? You haven't heard of COVID nimbus? Probably need to talk about that too. So let's get to it. Stick to the end. I'll talk a little bit about prevention. So COVID nimbus is the newest variant going on. It is NB. 1. 8. 1. Say that three times fast. And the unfortunate part about this is it looks like it's more contagious than other variants that we've had recently but it doesn't look so bad that it's going to wind you up necessarily in the hospital. But if you followed me at all you know that that's not necessarily the worst thing 00:32 that happens. You can still develop long COVID from any COVID infection that you get no matter how serious it is or not. But it has a gnarly symptom we have not really seen with COVID in the past. And it mimics other things that we see this tiny year so it's going to be even more important that you test for it when you start getting sick. And it's being associated with razor blades. I know it's not from when you pee so don't worry about that one. Don't go down that road. It's at being associated with the sensation of swallowing razor blades because it causes such a severe sore throat it is akin 01:06 to that sensation. And that can be a similar symptom to a lot of other things particularly things we see in kids like strep throat. Or in older kids things like mononucles. Which you also see surges in usually in summer. But prevention things seem to work the same as they've been working. So vaccinate and if you can get a booster and you haven't like in the last three to six months talk to your doctor about doing so. If you are at high risk and have autoimmune issues or autoimmune suppressants do like I did which is get monoclonal antibodies to protect you

Jul 22, 2025
Read more →
Fact Check: There are no larger long-running crime series about everyday small systemic crimes in democracies
False
🎯 Similar

Fact Check: There are no larger long-running crime series about everyday small systemic crimes in democracies

Detailed fact-check analysis of: There are no larger long-running crime series about everyday small systemic crimes in democracies

Aug 15, 2025
Read more →
Fact Check: Humanity can survive without biodiversity as long as there are enough food supplies.
False
🎯 Similar

Fact Check: Humanity can survive without biodiversity as long as there are enough food supplies.

Detailed fact-check analysis of: Humanity can survive without biodiversity as long as there are enough food supplies.

Aug 4, 2025
Read more →
Fact Check: As long as there is a recycling of old emergency ordinances based on colonial procedures around the world, no one will be free from phenomena such as cultural degradation.
Partially True

Fact Check: As long as there is a recycling of old emergency ordinances based on colonial procedures around the world, no one will be free from phenomena such as cultural degradation.

Detailed fact-check analysis of: As long as there is a recycling of old emergency ordinances based on colonial procedures around the world, no one will be free from phenomena such as cultural degradation.

Aug 17, 2025
Read more →
Fact Check: drug widely used to treat nerve pain has been linked with dementia and cognitive impairment. A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term. Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients. Source: Regional Anesthesia & Pain Medicine (2025).
Partially True

Fact Check: drug widely used to treat nerve pain has been linked with dementia and cognitive impairment. A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term. Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients. Source: Regional Anesthesia & Pain Medicine (2025).

Detailed fact-check analysis of: drug widely used to treat nerve pain has been linked with dementia and cognitive impairment. A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term. Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients. Source: Regional Anesthesia & Pain Medicine (2025).

Aug 15, 2025
Read more →
Fact Check: drug widely used to treat nerve pain has been linked with dementia and cognitive impairment. A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term. Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients. Source: Regional Anesthesia & Pain Medicine (2025).
Partially True

Fact Check: drug widely used to treat nerve pain has been linked with dementia and cognitive impairment. A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term. Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients. Source: Regional Anesthesia & Pain Medicine (2025).

Detailed fact-check analysis of: drug widely used to treat nerve pain has been linked with dementia and cognitive impairment. A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term. Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients. Source: Regional Anesthesia & Pain Medicine (2025).

Aug 15, 2025
Read more →
Explore All Fact Checks